22157.jpg
Global CAR-T Cell Therapy Market Research Report 2021: Approvals of Kymriah and Yescarta in Multiple Regions to Further Push Market Growth
September 21, 2021 04:23 ET | Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen; By Indication; By Regions: Segment Forecast, 2021 - 2028"...
DayOneBio_Logo_RGB_Square_large.jpg
Day One Appoints Jaa Roberson as Chief People Officer
September 13, 2021 07:00 ET | Day One Biopharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing...
Official_Bellicum_Logo_RGB.jpg
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
September 03, 2021 07:30 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
CidaraLogo (1).jpg
Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary
September 01, 2021 08:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for...
Official_Bellicum_Logo_RGB.jpg
Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
September 01, 2021 07:30 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, and The University of Texas...
Imagin - NEW LOGO.jpg
Imagin Medical Secures New $3 Million Convertible Note Financing
August 26, 2021 16:56 ET | Imagin Medical Inc.
Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board.Imagin Medical’s i/Blue™ Imaging...
Official_Bellicum_Logo_RGB.jpg
Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
August 12, 2021 16:05 ET | Bellicum Pharmaceuticals, Inc.
- Entered into a licensing agreement with two leading oncology research and treatment centers for use of CaspaCIDe® safety switch technology - - Enrollment continuing in Phase 1/2 dose-escalation...
Official_Bellicum_Logo_RGB.jpg
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 26, 2021 17:25 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, July 26, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced an equity...
Official_Bellicum_Logo_RGB.jpg
Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety Switch
June 28, 2021 07:30 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, June 28, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it has...
22157.jpg
2021 Insights on the CAR-T Cell Therapy Global Market - Overview of Clinical Trials
June 04, 2021 05:18 ET | Research and Markets
Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...